Bruce Morimoto

Bruce Morimoto

Company: Alto Neuroscience

Job title: Vice President - Drug Development

Seminars:

Chair’s Closing Remarks & End of Conference 5:00 pm

Read more

day: Conference Day Two PM

Chair: 10:45 am

Read more

day: Conference Day Two - Track Three

Roundtable Discussion: Discussing the Promises & Challenges of Elevating Neurodegenerative Therapeutics with a Combination Approach 2:00 pm

More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas. Are there opportunities to enhance therapies in phase I/II by combining with another treatment to improve them? What regulatory hurdles might arise when demonstrating the additional risks or benefits of a combination therapy? How can we…Read more

day: Conference Day One - Track Three

Chair’s Closing Remarks 5:15 pm

Read more

day: Conference Day One PM

Chair: 10:45 am

Read more

day: Conference Day One - Track Three

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.